Nifty Pharma hits record; GlaxoSmith, Aurobindo Pharma touch 52-week high

On Monday’s trading session, Nifty Pharma touched a record high at 15,950.80 level, up 0.9%. Among…

Zydus Lifesciences gets U.S. FDA approval for two products

The reference listed drug (RLD) of Diclofenac Sodium and Misoprostol Delayed Release Tablets is Arthrotec Delayed-Release…

Zydus Lifesciences Q4 net profit falls 25% YoY to ₹296.6 cr; declares dividend

Zydus Lifesciences net profit down 25.4% in Q4FY ending March 2023 from 296.6 crores 397.4 crore…

National Lipid Day 2023: Dyslipidemia Causes, Symptoms, Treatment & Facts

National Lipid Day is dedicated to raising awareness about the important role of lipids in our…

Zydus gets final USFDA nod to market epilepsy and menopause drugs

with a market valuation of 41,515.55 Cr, Zydus Lifesciences Ltd. Ltd. is a large-cap business that…

Zydus receives USFDA approval for generic antiepileptic drug

Eligible for 180 days of shared exclusivity for Brivaracetam tablets. Eligible for 180 days of shared…

Zydus Lifesciences Q4 profit down 41 per cent to Rs 397 crore

Image Source: PTI Zydus Lifesciences Q4 profit down 41 per cent to Rs 397 crore Pharmaceuticals…

The USFDA has approved the cholesterol drug Colestid. Zydus copy of

“The Company’s Brief New Drug Application is only the second generic application approved by the USFDA…